Statistics for InnoCan Pharma Corp (id:468 INNO)

Valuation metrics

Market cap

62.85M

Enterprise value

76.81M

Trailing P/E (ttm)

-12.94

Forward P/E

PEG ratio

Price/Sales (ttm)

2.58

Price/Book (mrq)

14.67

Enterprise Value/Revenue

2.25

Enterprise Value/EBITDA

-20.04

Overview

Shares outstanding

285.69M

Float

216.82M

Shares short

5.06K

% Held by insiders

0.22%

% Held by institutions

0.00%

Average volume (10 days)

71.72K

Average volume (90 days)

Price summary

52-Week low

0.18

52-Week high

0.41

52-Week change

-40.91%

Beta

2.96

50-Day moving average

0.22

200-Day moving average

0.26

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-17.80%

Operating margin

6.16%

Operational effectiveness

Return on assets

-23.77%

Return on equity

-56.52%

Income statement

Revenue (ttm)

0.09

Revenue per share (ttm)

0.09

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-3,833,068.00

Net income to common (ttm)

-6,064,716.00

Diluted EPS (ttm)

-0.02

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

7.25M

Total cash per share (mrq)

0.02

Total debt (mrq)

5.59K

Total Debt/Equity (mrq)

0.07

Current ratio (mrq)

321.80%

Book value per share (mrq)

0.02

Cash flow

Cash flow statement

-2,935,937.00

Levered free cash flow (LFCF)

1.82M